Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Jenving Clinical Trial Services AB
AB
Active
Org 5569048662
Nimbusgatan 2, 417 63
Göteborg
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2012
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Jenving Clinical Trial Services AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 144
1 155
1 183
1 444
1 325
Staff expenses
—
−698
−858
−925
−930
EBITDA
288
343
191
420
283
Depreciation & amort.
−5
−5
−5
−2
—
EBIT
283
338
186
418
283
Net financials
−1
29
14
13
2
Profit before tax
405
424
148
320
285
Tax
−88
−59
−33
−69
−62
Net profit
317
365
115
251
223
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 893
1 805
1 761
1 977
1 917
Equity
1 131
1 246
1 011
1 152
1 175
Long-term debt
0
—
—
—
—
Short-term debt
95
65
204
168
85
Total debt
95
65
204
168
85
Financial ratios
5-year trend
EBITDA margin
21.4%
This company
15.8%
Market median
+35% vs market
2021
2025
Equity ratio
61.3%
This company
38.2%
Market median
+60% vs market
2021
2025
Return on equity
19.0%
This company
18.4%
Market median
+3% vs market
2021
2025
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
2021
2025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
2021
2025
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Jenving Clinical Trial Services AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
